Ads

 

Ads

 

Ads

 

Top Pharmaceutical Companies in Europe List by Market Cap as on July-30-2023

Top Pharmaceutical Companies in Europe List by Market Cap as on July-30-2023. Biggest and Top Pharmaceutical Companies in Europe Companies by Market Cap. Largest Top Pharmaceutical Companies in Europe List by Market Cap as on July-30-2023.
Metatag Title
Top Pharmaceutical Companies in Europe
Metatag Abstract
Top Pharmaceutical Companies in Europe, Biggest Pharmaceutical Companies in Europe, Largest Pharmaceutical Companies in Europe.
  1. Grifols S.A.

    World Rank (Jan-05-2024)
    1,723
    Market Cap (Jan-05-2024)
    9.535 Billion USD
    World Rank (Jul-30-2023)
    1,788
    Market Cap (Jul-30-2023)
    9.235 Billion USD
    World Rank (Dec-25-2022)
    2,512
    Market Cap (Dec-25-2022)
    5.513 Billion USD
    World Rank (Jan-07-2022)
    1,735
    Market Cap (Jan-07-2022)
    11.02 Billion USD
    Annual Revenue in USD
    6,685 Million USD
    Annual Operating Income in USD
    774 Million USD
    Annual Net Income in USD
    229 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Pharmaceutical and healthcare company with headquarters is in Barcelona, Spain.

  2. Jazz Pharmaceuticals

    World Rank (Jan-05-2024)
    2,029
    Market Cap (Jan-05-2024)
    7.892 Billion USD
    World Rank (Jul-30-2023)
    1,938
    Market Cap (Jul-30-2023)
    8.393 Billion USD
    World Rank (Dec-25-2022)
    1,546
    Market Cap (Dec-25-2022)
    9.898 Billion USD
    World Rank (Jan-07-2022)
    2,179
    Market Cap (Jan-07-2022)
    8.26 Billion USD
    Annual Revenue in USD
    3,659 Million USD
    Annual Operating Income in USD
    512 Million USD
    Annual Net Income in USD
    -224 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Bio Pharmaceutical company with headquarters is in Dublin, Ireland.
  3. Hikma Pharmaceuticals

    World Rank (Jan-05-2024)
    2,843
    Market Cap (Jan-05-2024)
    5.182 Billion USD
    World Rank (Jul-30-2023)
    2,549
    Market Cap (Jul-30-2023)
    5.954 Billion USD
    World Rank (Dec-25-2022)
    3,183
    Market Cap (Dec-25-2022)
    4.138 Billion USD
    World Rank (Jan-07-2022)
    2,587
    Market Cap (Jan-07-2022)
    6.71 Billion USD
    Annual Revenue in USD
    3,233 Million USD
    Annual Operating Income in USD
    619 Million USD
    Annual Net Income in USD
    241 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Hikma Pharmaceuticals is a pharmaceutical company. It develop, manufacture and market nearly 700 quality branded and non branded generic medicines worldwide. The company categories include anti infectives, cardiovascular, central nervous system, diabetes, oncology, pain management and respiratory. The headquarters is in UK.

    Facts About Company

    HIKMA PHARMACEUTICALS annual revenue was 2,517 million GBP and annual net income was 188 million GBP generated for period year ending Dec-2022.

    HIKMA PHARMACEUTICALS annual revenue was 2,553 million GBP and annual net loss was 421 million GBP generated for period year ending Dec-2021.

    As on 2022, HIKMA PHARMACEUTICALS had 8800 employees.

  4. Orion Oyj

    World Rank (Jan-05-2024)
    2,507
    Market Cap (Jan-05-2024)
    6.095 Billion USD
    World Rank (Jul-30-2023)
    2,750
    Market Cap (Jul-30-2023)
    5.458 Billion USD
    World Rank (Dec-25-2022)
    1,852
    Market Cap (Dec-25-2022)
    7.917 Billion USD
    World Rank (Jan-07-2022)
    2,972
    Market Cap (Jan-07-2022)
    5.69 Billion USD
    Annual Revenue in USD
    1,477 Million USD
    Annual Operating Income in USD
    481 Million USD
    Annual Net Income in USD
    385 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Orion Corporation is a Pharmaceutical company. It is investing EUR 17 million in its production facilities in Turku. The company is investing in a new packaging line for anticancer drugs and expanding its cream manufacturing department. It net sales in 2019 were EUR 1,051 million and the company employed about 3,300 employees at the end of the year. The headquarters is in Finland.
  5. Dechra Pharmaceuticals

    World Rank (Jan-05-2024)
    2,696
    Market Cap (Jan-05-2024)
    5.566 Billion USD
    World Rank (Jul-30-2023)
    2,759
    Market Cap (Jul-30-2023)
    5.433 Billion USD
    World Rank (Dec-25-2022)
    3,556
    Market Cap (Dec-25-2022)
    3.614 Billion USD
    World Rank (Jan-07-2022)
    2,623
    Market Cap (Jan-07-2022)
    6.58 Billion USD
    Annual Revenue in USD
    963 Million USD
    Annual Operating Income in USD
    8 Million USD
    Annual Net Income in USD
    -34 Million USD
    Annual Results for Period Ending
    Jun-2023 ending period
    Headquarters Country
    Stock Category
    Company Profile

    Dechra Pharmaceuticals is a specialist Veterinary Pharmaceuticals and related products business. It expertise is in the development, manufacture and sales and marketing of high quality products exclusively for veterinarians worldwide. The headquarters is in UK.

    Facts About Company

    Dechra Pharmaceuticals annual revenue was 681 million GBP and annual net income was 58 million GBP generated for period year ending Jun-2022.

    Dechra Pharmaceuticals annual revenue was 608 million GBP and annual net income was 55 million GBP generated for period year ending Jun-2021.

    As on 2023, Dechra Pharmaceuticals had 2400 employees.

  6. Perrigo Company

    World Rank (Jan-05-2024)
    3,172
    Market Cap (Jan-05-2024)
    4.552 Billion USD
    World Rank (Jul-30-2023)
    3,003
    Market Cap (Jul-30-2023)
    4.946 Billion USD
    World Rank (Dec-25-2022)
    3,011
    Market Cap (Dec-25-2022)
    4.446 Billion USD
    World Rank (Jan-07-2022)
    3,057
    Market Cap (Jan-07-2022)
    5.45 Billion USD
    Annual Revenue in USD
    4,451 Million USD
    Annual Operating Income in USD
    121 Million USD
    Annual Net Income in USD
    -140 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Perrigo is a leading global healthcare company, focused on providing value to its customers and consumers by delivering Quality Affordable Healthcare Products. Perrigo has built a unique business model that is best described as the convergence of a fast-moving consumer goods company, a high-quality pharmaceutical manufacturing organization and a world-class supply chain network. Perrigo is the world's largest manufacturer of OTC healthcare products and supplier of infant formulas for the store brand market.
  7. H. Lundbeck A/S

    World Rank (Jan-05-2024)
    3,042
    Market Cap (Jan-05-2024)
    4.760 Billion USD
    World Rank (Jul-30-2023)
    3,123
    Market Cap (Jul-30-2023)
    4.724 Billion USD
    World Rank (Dec-25-2022)
    3,498
    Market Cap (Dec-25-2022)
    3.704 Billion USD
    World Rank (Jan-07-2022)
    3,323
    Market Cap (Jan-07-2022)
    4.91 Billion USD
    Annual Revenue in USD
    2,697 Million USD
    Annual Operating Income in USD
    422 Million USD
    Annual Net Income in USD
    283 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Lundbeck is a global pharmaceutical company specialized in brain diseases. Headquarters is in Denmark.

    Lundbeck employs approximately 5,800 employees in more than 50 countries. They have production facilities in Denmark, France and Italy and their research centers are based in Denmark and California.

  8. GW Pharmaceuticals

    World Rank (Jan-05-2024)
    3,962
    World Rank (Jul-30-2023)
    3,962
    World Rank (Dec-25-2022)
    3,962
    World Rank (Jan-07-2022)
    3,962
    Annual Revenue in USD
    527 Million USD
    Annual Net Income in USD
    -58 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    Company Profile

    GW Pharmaceuticals is a position in the development of plant derived cannabinoid therapeutics through it proven drug discovery and development processes intellectual property portfolio and regulatory and manufacturing expertise. The headquarters is in UK.

  9. Avadel Pharmaceuticals

    World Rank (Jan-05-2024)
    7,226
    Market Cap (Jan-05-2024)
    1.350 Billion USD
    World Rank (Jul-30-2023)
    8,305
    Market Cap (Jul-30-2023)
    1.092 Billion USD
    World Rank (Dec-25-2022)
    13,348
    Market Cap (Dec-25-2022)
    0.434 Billion USD
    World Rank (Jan-07-2022)
    14,705
    Market Cap (Jan-07-2022)
    0.41 Billion USD
    Annual Revenue in USD
    22 Million USD
    Annual Net Income in USD
    7 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
  10. Cosmo Pharmaceuticals

    World Rank (Jan-05-2024)
    8,071
    Market Cap (Jan-05-2024)
    1.110 Billion USD
    World Rank (Jul-30-2023)
    9,786
    Market Cap (Jul-30-2023)
    0.819 Billion USD
    World Rank (Dec-25-2022)
    7,951
    Market Cap (Dec-25-2022)
    1.093 Billion USD
    World Rank (Jan-07-2022)
    8,737
    Market Cap (Jan-07-2022)
    1.14 Billion USD
    Annual Revenue in USD
    65 Million USD
    Annual Net Income in USD
    21 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile

    COSMO Pharmaceutical is a specialty pharmaceutical company with a focus on gastroenterology and endoscopy. The company annual revenue is 7,26,424 million JPY, annual operating income is 60.9 million EUR and total assets are 596 million EUR for year ending Dec-2020. The headquarters is in Ireland.

Share

Ads